Dapsone
- Product NDC
- 47781-334
- 11-digit product format
- 477810334
- Labeler code
- 47781
- Product ID
- 47781-334_18d1a5b2-d6be-f170-0c83-43234c4c0d0d
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- dapsone
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Alvogen Inc.
- Application
- ANDA205429
- Marketing category
- ANDA
- Marketing start
- 2016-06-13
- Marketing end
- 0000-00-00
- Substance
- DAPSONE
- Active strength
- 100 mg/1
- Pharmacologic classes
- Sulfone [EPC],Sulfones [CS]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 47781-334-31 | 47781033431 | 2 BLISTER PACK in 1 CARTON (47781-334-31) > 15 TABLET in 1 BLISTER PACK | 2 blister pack | 2016-06-13 | 0000-00-00 | No | No | Current |